{"product_id":"trosyd-ginecologico-crema-vag-78-g-1","title":"TROSYD GYNECOL 1% VAGINAL CREAM 1 TUBE OF 78 G WITH APPLICATOR","description":"\u003cb\u003eName\u003c\/b\u003e\u003cbr\u003e \u003cb\u003eTROSYD GYNECOLOGICAL 1% vaginal cream\u003cbr\u003e TROSYD GYNECOLOGICAL 50 mg ovules\u003c\/b\u003e\u003cbr\u003e Equivalent medicine\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cb\u003eWhat it is and what it is used for\u003c\/b\u003e\u003cbr\u003e Vulvovaginal mycoses (Trichophyton mentagrophytes, Epidermophyton, Malassetia furfur, Candida albicans, Nocardia minutissima).\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cb\u003eWhat you need to know before taking the medicine\u003c\/b\u003e\u003cbr\u003e Hypersensitivity to the active substance or to any of the excipients.\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cb\u003eWarnings and precautions\u003c\/b\u003e\u003cbr\u003e \u003cem\u003e\u003cu\u003ePregnancy and breastfeeding\u003c\/u\u003e\u003c\/em\u003e \u003cbr\u003eAsk your doctor or pharmacist for advice before taking any medicine.\u003cbr\u003e\u003cbr\u003e Pregnancy\u003cbr\u003e In animal studies, econazole nitrate has not shown teratogenic effects but has been shown to be foetotoxic at high doses. The relevance of this effect to humans is unknown.\u003cbr\u003e Due to vaginal absorption, TROSYD GINECOLOGICO should not be used during the first trimester of pregnancy unless the doctor considers it necessary for the health of the patient.\u003cbr\u003e TROSYD GYNECOLOGICO can be used during the second and third trimester if the potential benefits outweigh the possible risks to the fetus.\u003cbr\u003e\u003cbr\u003e Breastfeeding\u003cbr\u003e Following oral administration of econazole nitrate to lactating rats, econazole and\/or its metabolites were excreted in milk and were detected in nursing pups.\u003cbr\u003e It is not known whether econazole nitrate is excreted in human breast milk.\u003cbr\u003e Caution should be exercised when TROSYD GYNECOLOGICO is administered to women who are breastfeeding.\u003cbr\u003e   \u003cbr\u003e\u003cu\u003e\u003cem\u003eEffects on ability to drive and use machines\u003c\/em\u003e\u003c\/u\u003e\u003cbr\u003e None known.\u003cbr\u003e\u003cbr\u003e Concomitant use of latex-containing condoms or diaphragms with anti-infective vaginal preparations may decrease the effectiveness of latex contraceptives. Therefore, products such as TROSYD GINECOLOGICO cream should not be used concomitantly with diaphragms or latex-containing condoms. Patients using spermicidal contraceptives should consult their doctor as local vaginal treatments may inactivate the effectiveness of the spermicidal contraceptive (see section \"Interactions\").\u003cbr\u003e TROSYD GYNECOLOGICO should not be used in combination with other products for the internal or external treatment of the genitals. If marked irritation or sensitization occurs, treatment should be discontinued.\u003cbr\u003e Patients with sensitivity to imidazoles have also reported sensitivity to econazole nitrate.\u003cbr\u003e TROSYD GYNECOLOGICO is not for ophthalmic or oral use.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cb\u003ePossible side effects\u003c\/b\u003e\u003cbr\u003e Like all medicines, TROSYD GYNECOLOGICO can cause side effects, although not everybody gets them.\u003cbr\u003e The most frequently reported adverse reactions in clinical studies were reactions at the application site, such as burning sensation and stinging pain, itching and erythema. Use of the product, especially if prolonged, may give rise to sensitization phenomena. In case of hypersensitivity reactions, it is necessary to interrupt the treatment and institute appropriate therapy; a similar procedure must be followed in case of development of non-sensitive microorganisms.\u003cbr\u003e The following table lists the ADRs that have been reported with the use of the gynaecological formulation in clinical trials or in post-marketing experience, including the above-mentioned adverse reactions (ADRs - Adverse Drug Reactions). \u003cbr\u003eFrequency categories are reported according to the following convention: very common (≥ 1\/10); common (≥ 1\/100 to \u0026lt; 1\/10); uncommon (≥ 1\/1,000 to \u0026lt;1\/100); rare (≥ 1\/10,000 to \u0026lt; 1\/1,000); very rare (\u0026lt; 1\/10,000); and not known (frequency cannot be estimated from the available data from clinical trials).\u003cbr\u003e All ADRs with known incidence (common or uncommon) are from clinical trial data and all ADRs with unknown incidence are from postmarketing data.\u003cbr\u003e\u003cbr\u003e\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"3\"\u003e\n\u003ctr\u003e\n\n\u003ctd rowspan=\"3\"\u003e \u003cb\u003eClassification by\u003cbr\u003e systems and organs\u003c\/b\u003e\n\u003c\/td\u003e\n\n\u003ctd colspan=\"3\"\u003e \u003cb\u003eAdverse Drug Reactions\u003c\/b\u003e\n\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\u003ctr\u003e\u003ctd colspan=\"3\"\u003e \u003cb\u003eFrequency class\u003c\/b\u003e\n\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\n\n\u003ctd\u003e\u003c\/td\u003e\n\n\u003ctd\u003e\u003c\/td\u003e\n\n\u003ctd\u003e \u003cb\u003eNot known\u003c\/b\u003e\n\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\u003ctr\u003e\n\n\u003ctd\u003e \u003cb\u003eSkin and body diseases\u003cbr\u003e of the subcutaneous tissue\u003c\/b\u003e\n\u003c\/td\u003e\n\n\u003ctd\u003e\u003c\/td\u003e\n\n\u003ctd\u003e\u003c\/td\u003e\n\n\u003ctd\u003e Angioedema\u003cbr\u003e Rash\u003cbr\u003e Urticaria\u003cbr\u003e Erythema\u003cbr\u003e Itching\u003cbr\u003e Burning sensation\u003cbr\u003e Hypersensitivity\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e Following the instructions in the package leaflet reduces the risk of side effects.\u003cbr\u003e\u003cbr\u003e \u003cb\u003eReporting of side effects\u003c\/b\u003e \u003cbr\u003eIf you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system at: \u003cu\u003ehttps:\/\/www.aifa.gov.it\/content\/segnalazionireazioni-avverse\u003c\/u\u003e .\u003cbr\u003e By reporting side effects you can help provide more information on the safety of this medicine.","brand":"GIULIANI SPA","offers":[{"title":"Default Title","offer_id":50221862322510,"sku":"025055029","price":15.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0845\/6214\/9710\/files\/TE004-H0009069.png?v=1768753478","url":"https:\/\/farmaspeed.it\/en\/products\/trosyd-ginecologico-crema-vag-78-g-1","provider":"Farmaspeed","version":"1.0","type":"link"}